Discontinuation report DAKLINZA

Last updated on 2018-09-28
Report ID 62549
Drug Identification Number 02444747
Brand name DAKLINZA
Common or Proper name daclatasvir dihydrochloride
Company Name BRISTOL-MYERS SQUIBB CANADA
Active Ingredient(s) Daclatasvir
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 Bottle X 28
ATC code J05AP
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-07-31
Actual discontinuation date
Remaining supply date 2019-07-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Stock will be available until July 31st, 2019
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005